| Bioactivity | Antiviral agent 46 (compound 4) is a derivative of cannabidiol (CBD) with anti-SARS-CoV-2 (IC50: 1.90 μM) and ACE2 activity (IC50: 1.37 μM)[1]. |
| Target | 1.37 μM (ACE2), 1.90 μM (SARS-CoV-2) |
| Name | Antiviral agent 46 |
| CAS | 877660-90-7 |
| Formula | C21H32O2 |
| Molar Mass | 316.48 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Marques GVL, et al. Synthesis of cannabidiol-based compounds as ACE2 inhibitors with potential application in the treatment of COVID-19. Eur J Med Chem. 2023 Nov 15;260:115760 |
Antiviral agent 46
CAS: 877660-90-7 F: C21H32O2 W: 316.48
Antiviral agent 46 (compound 4) is a derivative of cannabidiol (CBD) with anti-SARS-CoV-2 (IC50: 1.90 μM) and ACE2 acti
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.